NCT00508365 - Evaluation of Potential for Orthostatic Hypotension in Elderly Hypertensives | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 25, 2007

Primary Completion Date

June 3, 2008

Study Completion Date

June 3, 2008

Conditions

Hypertension

Interventions

DRUG

Carvedilol CR capsules

The carvedilol micropump (COREG) CR cpsules will be available with doses of 20 milligrams and 40 milligrams administered orally once daily.

DRUG

Placebo

Placebo capsules to match each dose level will be provided.

DRUG

Lisinopril

Lisinopril will be available as 10 milligrams tablets administered orally once daily.

Trial Locations (20)

33134

GSK Investigational Site, Coral Gables

33169

GSK Investigational Site, Miami

33409

GSK Investigational Site, West Palm Beach

34239

GSK Investigational Site, Sarasota

36207

GSK Investigational Site, Anniston

44122

GSK Investigational Site, Cleveland

46260

GSK Investigational Site, Indianapolis

58103

GSK Investigational Site, Fargo

73132

GSK Investigational Site, Oklahoma City

77081

GSK Investigational Site, Houston

78229

GSK Investigational Site, San Antonio

78704

GSK Investigational Site, Austin

83704

GSK Investigational Site, Boise

85308

GSK Investigational Site, Glendale

89119

GSK Investigational Site, Las Vegas

90211

GSK Investigational Site, Beverly Hills

90806

GSK Investigational Site, Long Beach

92801

GSK Investigational Site, Anaheim

97239

GSK Investigational Site, Portland

07601

GSK Investigational Site, Hackensack